Cargando…
Immune Checkpoint Inhibitors in People Living with HIV/AIDS: Facts and Controversies
Immune checkpoint inhibitors (ICIs) are reshaping the landscape of cancer treatment, redefining the prognosis of several tumors. They act by restoring the cytotoxic activity of tumor-specific T lymphocytes that are in a condition of immune exhaustion. The same condition has been widely described in...
Autores principales: | Castelli, Valeria, Lombardi, Andrea, Palomba, Emanuele, Bozzi, Giorgio, Ungaro, Riccardo, Alagna, Laura, Mangioni, Davide, Muscatello, Antonio, Bandera, Alessandra, Gori, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467545/ https://www.ncbi.nlm.nih.gov/pubmed/34571876 http://dx.doi.org/10.3390/cells10092227 |
Ejemplares similares
-
Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation
por: Alagna, Laura, et al.
Publicado: (2020) -
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results
por: Lombardi, Andrea, et al.
Publicado: (2021) -
Nocardia Infections in the Immunocompromised Host: A Case Series and Literature Review
por: Palomba, Emanuele, et al.
Publicado: (2022) -
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: a question needing an answer
por: Lombardi, A., et al.
Publicado: (2020) -
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)